ESS Tech, Inc. Form 8-K Summary
Business Context and Reporting Period
ESS Tech, Inc. filed a Form 8-K concerning compliance with the New York Stock Exchange’s continued listing requirements. The earliest reported event occurred on March 6, 2024; the report was signed March 8, 2024. The filing relates to the Company’s common stock trading under the symbol GWH on the NYSE.
Financial Metrics and Liquidity
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity balances, or other operating financial metrics. It references potential liquidity concerns in its forward-looking statements but does not provide a clear quantitative value or specific liquidity update.
Material Changes Versus the Prior Comparable Period
- On March 6, 2024, ESS Tech received an NYSE notice stating that its common stock failed to satisfy Section 802.01C because its average closing price was below $1.00 per share over a consecutive 30-trading-day period.
- As of March 5, 2024, the 30-trading-day average closing price was $0.94.
- The notice is a deficiency notice, not a delisting notice, and does not currently affect the listing or trading of the common stock on the NYSE.
Guidance, Outlook, Risks, and Unusual Items
- The Company must notify the NYSE within 10 business days of receiving the notice that it intends to cure the deficiency. The Company stated that it intends to provide that notification.
- The Company generally has six months from receipt of the notice to regain compliance, subject to possible NYSE extension.
- Compliance may be regained if, on the last trading day of a calendar month during the cure period, the stock has a closing price of at least $1.00 and a 30-trading-day average closing price of at least $1.00.
- The Company is evaluating possible remedies, including a reverse stock split. Any remedy requiring shareholder approval must be approved no later than the next annual meeting and implemented promptly thereafter.
- There is no assurance that the Company will regain compliance during the initial cure period, any extension, or at all. Failure to regain compliance could result in delisting.
- The Company issued a March 8, 2024 press release regarding the NYSE notice, filed as Exhibit 99.1.
Most Important Facts to Verify
- Whether ESS Tech submitted its compliance plan to the NYSE within the required 10-business-day period.
- Whether the stock price and 30-trading-day average subsequently returned to at least $1.00.
- Whether the NYSE granted any extension or imposed additional requirements.
- Whether the Company proposes a reverse stock split or another shareholder-approved action.
- Current liquidity, financing needs, and any related risks, which are not quantified in this filing.